-
Why Pfizer's Future Looks Better in 2021
Post on 1/26/21
-
Merck Gives Up on Coronavirus Vaccines
Post on 1/26/21
-
Caladrius Biosciences Closes $25.0 Million Private Placement
Post on 1/25/21
-
Seelos Therapeutics Proposes Public Offering of Common Stock
Post on 1/25/21
-
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock
Post on 1/25/21
-
Citius Pharmaceuticals Announces $20.0 Million Private Placement
Post on 1/25/21
-
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
Post on 1/25/21
-
TScan Therapeutics Closes $100 Million Series C Financing
Post on 1/25/21
-
Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update
Post on 1/25/21
-
What Kind of Deals Is Pfizer Planning for the Next Few Years?
Post on 1/25/21
-
Why Pfizer's Future Looks Better in 2021
Post on 1/25/21
-
Is Johnson & Johnson a Buy?
Post on 1/22/21
-
Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program
Post on 1/22/21
-
Caladrius Biosciences Announces $25M Private Placement
Post on 1/21/21
-
Phio Pharmaceuticals Announces $14.0 Million Private Placement
Post on 1/21/21
-
OncoSec Medical Prices of $42.0 Million Public Offering of Common Stock
Post on 1/21/21
-
Synaptogenix Announces $14.0 Million Private Placement
Post on 1/21/21
-
Vestar Capital Partners Makes a Majority Investment in Dr. Praeger's Sensible Foods
Post on 1/21/21
-
The Vistria Group and Excellere Partners Invest in SCA Pharmaceuticals
Post on 1/21/21
-
Caladrius Biosciences Announces $25.0 Million Private Placement
Post on 1/21/21
-
CorMedix to Begin Trading on the Nasdaq Stock Exchange
Post on 1/21/21
-
Bridges Consumer Healthcare Portfolio Company of Charlesbank Capital Partners Acquires Clarion Brands from Swander Pace Capital
Post on 1/21/21
-
Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant
Post on 1/21/21
-
OncoSec Medical Proposes Public Offering of Common Stock
Post on 1/20/21
-
Turnstone Biologics Acquires Novel Cell Therapy Platform
Post on 1/20/21
New York
